Cookies disclaimer

Continue Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device. Additional information can be found under the cookie section of this page.

Value, Access and Regulatory Strategy Workshop    Back

Drug Information Association Course Type: Short courses (CPD) Start Date: 17 Oct 2017
Location: Basel, Switzerland Duration: Full time - 2 Days Fees/total cost: EUR 1,585.00

Description

Leaders across industry and health authorities agree that finding answers to market access are critical to the future of delivering breakthrough medicines to patients. Unfortunately, policies and practice do not always marry up.

This meeting is the starting point to engage professionals working with value and regulatory strategies. HTA bodies and regulators are breaking down silos, facilitating access to new medicines and increasing efficiencies in assessment processes. R&D process will need to be able to generate evidence for registration and reimbursement.

Bringing together the policy makers and the policy implementers, to keep you ahead of the game of practical solutions.

DIA shares insights in advance of this conference:
• Webinar: Approvals and Access – Overcoming the Final Hurdle of Drug Development
• Podcast: EBE Plots Path from “Flawed Underfunded Biotech System”

Full time

Start date:
17 Oct 2017
Apply until:
17 Oct 2017
Duration:
2 Days
Teaching method:
Face-To-Face
Language:
English
Venue:
Basel, Switzerland
Standard applicant fee:
EUR 1,585.00

LifeTrain

Course Provider Details

Course contact information

Carolin Doerflinger
Event Manager
Planning & Development
EMEA@DIAglobal.org
Feedback lifetrain.eu